Blog: COLLEGIUM PHARMACEUTICAL, INC : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 2.02 Results of Operations and Financial Condition.

On August 4, 2022, Collegium Pharmaceutical, Inc. issued a press release
announcing its financial results for the quarterly period ended June 30, 2022.
The full text of the press release issued in connection with the announcement is
attached hereto as Exhibit 99.1 and is being furnished, not filed, under Item
2.02 of this Current Report on Form 8-K.

Item 7.01Regulation FD Disclosure.

On August 4, 2022, Collegium Pharmaceutical, Inc. released an earnings
presentation. The presentation is attached hereto as Exhibit 99.2 and is being
furnished, not filed, under Item 7.01 of this Current Report on Form 8-K.


Item 9.01         Financial Statements and Exhibits.

(d) Exhibits

Exhibit
No.            Description
99.1             Press Release, dated August 4, 2022
99.2             Earnings Presentation, dated August 4, 2022
104            Cover Page Interactive Data File (embedded within the Inline XBRL
               document)

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s